奎斯特诊疗（DGX）今日盘中大涨5.09%，引起了市场的广泛关注。
消息面上，公司发布了2025年第四季度及全年财报，其营收和每股收益均超出市场预期。同时，公司对2026年的业绩给出了乐观指引，预计收入和调整后每股利润均将高于分析师平均预期，这主要得益于市场对其诊断测试的强劲需求，尤其是非急诊手术需求的增加。此外，公司高管确认，随着相关联邦资金法案的通过，2026年的《保护医保准入法案》（PAMA）将不会对公司运营产生影响，消除了潜在的监管不确定性。
另一方面，公司宣布将季度股息上调7.5%至每股0.86美元，实现了连续十五年的股息增长，并同步宣布追加10亿美元的股票回购授权。这些积极的股东回报措施进一步增强了投资者信心，共同推动了股价的显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.